Medical Foods Market Research Report- Forecast till 2027

Global Medical Foods Market Research Report–Nutritional Ingredients (Vitamins Minerals, Proteins, Omega-3, Isoflavones, Phytosterols), Ailment (Alzheimer’s Diseases, Diabetic Neuropathy, Nutritional Deficiency, Depression), Form and Region Forecast till 2027

ID: MRFR/Pharma/3484-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Intended Audience



  • Pharmaceutical industry

  • Nutritional processing industry

  • Medical food industry

  • E-commerce industry

  • Traders, importers and exporters


Market Synopsis of Medical Foods Market:


Market Definition:


Medical foods are principally formulated food products intended to be used under the supervision of medical and other appropriate health professionals. They work by supplying nutrition, not available in a normal diet, for the management of certain diseases such as Alzheimer’s, diabetic neuropathy, nutritional deficiency, depression, and others. They can be administered through oral or enteral route depending on the absorption capacity of the patient. Moreover, medical foods are made with Generally Recognized As Safe (GRAS) ingredients which include vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others.


Market Scenario:
Medical foods are custom made liquid solutions used entirely, to treat consumers suffering from various diseases. Increasing chronic diseases among the growing population is driving the growth of the market. Moreover, nutritional deficiency is a common issue observed globally which will propel the growth of the global medical foods market.


Growing geriatric population is a major factor driving the growth of medical foods. Moreover, increasing awareness of nutritional benefits will surge the growth of medical foods. However, lack of knowledge among the consumers regarding medical foods is a major restraint to the market growth.


  Key Findings



  • Manufacturers are bringing more products to market that address metabolic processes

  • Till date, majority of medical foods are administered through the oral feeding


Segments:
Medical foods market is segmented on the basis of nutritional ingredients such as vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others. Among all, proteins segment is dominating the market. However, omega-3 is witnessed to be the fastest growing segment in nutritional ingredients used for medical foods.


Based on the form, medical foods market is segmented into pills, powder and others. Among all, pills segment is projected to be growing at the fastest rate and includes tablets and capsules. However, powder form is dominating the market over the past years.


On the basis of ailment, medical foods market is segmented into Alzheimer’s diseases, diabetic neuropathy, nutritional deficiency, depression, and others. Among all, diabetic neuropathy is dominating the market as majority of the diabetic consumers suffer from some kind of neuropathy. However, nutritional deficiency segment is witnessed to be the fastest growing segment over the forecast period.   


 Regional Analysis:
The global medical foods market is segmented into North America, Europe, Asia Pacific and rest of the world (RoW). North America is dominating the global market followed by Europe. Increasing awareness of medical foods in the U.S. and growing problem of Alzheimer’s diseases is driving the market for medical foods in this region.


Asia Pacific is projected to be the fastest growing region in which the major contributor is China. Continuous innovation and improved education towards medical foods will positively impact the market for rest of the world.         


Key Players
Some of the key players profiled in the global medical foods market are Danone (France), Nestlé (Switzerland), Abbott (U.S.), Mead Johnson & Company, LLC (U.S.), Primus Pharmaceuticals Inc. (U.S.), Targeted Medical Pharma Inc. (U.S.), Fresenius Kabi AG (Germany)


The global medical foods market is segmented under the following regions


North America



  • U.S.

  • Canada

  • Mexico


Europe



  • Germany

  • France

  • Italy

  • Spain

  • U.K

  • Rest of Europe


Asia Pacific



  • China

  • India

  • Australia

  • Japan

  • Rest of Asia Pacific


Rest of the world



  • Brazil

  • Argentina

  • South Africa

  • Others 


The report for Global Medical foods market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size    2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Nutritional Ingredients, Ailment, Form
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Danone (France), Nestlé (Switzerland), Abbott (U.S.), Mead Johnson & Company, LLC (U.S.), Primus Pharmaceuticals Inc. (U.S.), Targeted Medical Pharma Inc. (U.S.), Fresenius Kabi AG (Germany)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing chronic diseases
  • Growing geriatric population
  • Increasing awareness of nutritional benefits


  • Frequently Asked Questions (FAQ) :


    Medical foods are foods created specifically to counter the nutritional deficiencies underpinning a specific disease, in order to cure the disease and help the patient in recuperating rapidly.

    Lack of knowledge about medical foods among patients is the major restraint on the global market.

    Increasing awareness is likely to be the major driver for the medical foods market over the forecast period.

    North America is the dominant regional market for medical foods, followed by Europe.

    Key players in the medical foods market include Danone, Nestle, and Abbott, among others.

    Table of Content

    Chapter 1. Methodology and Scope

    1.1. Research Methodology

    1.1.1 Initial Data Exploration

    1.1.2 Statistical Modelling and Forecast

    1.1.3 Industry Insights and Validation

    1.2. Data Sources

    Chapter 2. Executive Summary

    2.1. Medical foods Industry Market Synopsis, 2020-2027

    2.1.1 Business Trends

    2.1.2 Product Nutritional ingredients Trends

    2.1.3 Product Form Trends

    2.1.4 Product Ailment Trends

    Chapter 3 Medical foods market Industry Insights

    3.1 Industry Segmentation

    3.2 Industry Size and Forecast

    3.3 Industry Ecosystem Analysis

    3.4 Industry Impact forces

    3.4.1 Growth Drivers

    3.4.1.1 Increasing chronic diseases among growing population

    3.4.1.2 Growing nutritional deficiency

    3.4.2 Industry Pitfalls & Challenges

    3.4.2.1 Lack of awareness

    3.4.2.2 Requirement of strong scientific support

    3.5 Growth Potential Analysis

    3.6 Company Market Share Analysis, 2020

    3.7 Porter’s analysis

    3.8 PESTEL analysis

    Chapter 4 Medical foods market by Nutritional ingredients Insights

    4.1 Global Medical foods Market Volume Share by Nutritional ingredients, 2020-2027

    4.1.1 Vitamins and minerals

    4.1.1.1 Market Estimates & Forecast, 2020-2027

    4.1.2 Proteins

    4.1.2.1 Market Estimates & Forecast, 2020-2027

    4.1.3 Omega-3

    4.1.3.1 Market Estimates & Forecast, 2020-2027

    4.1.4 Isoflavones

    4.1.4.1 Market Estimates & Forecast, 2020-2027

    4.1.5 Phytosterols

    4.1.5.1 Market Estimates & Forecast, 2020-2027

    4.1.6 Others

    4.1.6.1 Market Estimates & Forecast, 2020-2027

    Chapter 5 Medical foods market by Form Insights

    5.1 Global Medical foods Market Volume Share by Form, 2020-2027

    5.1.1 Pills

    5.1.1.1 Market Estimates & Forecast, 2020-2027

    5.1.2 Powder

    5.1.2.1 Market Estimates & Forecast, 2020-2027

    5.1.3 Others

    5.1.3.1 Market Estimates & Forecast, 2020-2027

    Chapter 6 Medical foods market by Ailment Insights

    6.1 Global Medical foods Market Volume Share by Ailment, 2020-2027

    6.1.1 Alzheimer’s diseases

    6.1.1.1 Market Estimates & Forecast, 2020-2027

    6.1.1.2 Market Estimates & Forecast by Region, 2020-2027

    6.1.2 Diabetic Neuropathy

    6.1.2.1 Market Estimates & Forecast, 2020-2027

    6.1.2.2 Market Estimates & Forecast by Region, 2020-2027

    6.1.3 Nutritional deficiency

    6.1.3.1 Market Estimates & Forecast, 2020-2027

    6.1.3.2 Market Estimates & Forecast by Region, 2020-2027

    6.1.4 Depression

    6.1.4.1 Market Estimates & Forecast, 2020-2027

    6.1.4.2 Market Estimates & Forecast by Region, 2020-2027

    6.1.5 Others

    6.1.5.1 Market Estimates & Forecast, 2020-2027

    6.1.5.2 Market Estimates & Forecast by Region, 2020-2027

    Chapter 7 Medical foods market Regional Insights

    7.1 Medical foods Market Volume Share by Region, 2020-2027.

    7.2 North America

    7.2. A Market Estimates & Forecast, 2020-2027

    7.2. B Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.2. C Market Estimates & Forecast, by Form, 2020-2027

    7.2. D Market Estimates & Forecast, by Ailment, 2020-2027

    7.2.1 U.S.

    7.2.1.1 Market Estimates & Forecast, 2020-2027

    7.2.1.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.2.1.3 Market Estimates & Forecast, by Form, 2020-2027

    7.2.1.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.2.2 Canada

    7.2.2.1 Market Estimates & Forecast, 2020-2027

    7.2.2.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.2.2.3 Market Estimates & Forecast, by Form, 2020-2027

    7.2.2.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.2.3 Mexico

    7.2.3.1 Market Estimates & Forecast, 2020-2027

    7.2.3.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.2.3.3 Market Estimates & Forecast, by Form, 2020-2027

    7.2.3.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.3 Europe

    7.3. A Market Estimates & Forecast, 2020-2027

    7.3. B Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.3. C Market Estimates & Forecast, by Form, 2020-2027

    7.3. D Market Estimates & Forecast, by Ailment, 2020-2027

    7.3.1 Germany

    7.3.1.1 Market Estimates & Forecast, 2020-2027

    7.3.1.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.3.1.3 Market Estimates & Forecast, by Form, 2020-2027

    7.3.1.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.3.2 U.K

    7.3.2.1 Market Estimates & Forecast, 2020-2027

    7.3.2.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.3.2.3 Market Estimates & Forecast, by Form, 2020-2027

    7.3.2.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.3.3 France

    7.3.3.1 Market Estimates & Forecast, 2020-2027

    7.3.3.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.3.3.3 Market Estimates & Forecast, by Form, 2020-2027

    7.3.3.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.3.4 Italy

    7.3.4.1 Market Estimates & Forecast, 2020-2027

    7.3.4.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.3.4.3 Market Estimates & Forecast, by Form, 2020-2027

    7.3.4.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.4 Asia Pacific

    7.4. A Market Estimates & Forecast, 2020-2027

    7.4. B Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.4. C Market Estimates & Forecast, by Form, 2020-2027

    7.4. D Market Estimates & Forecast, by Ailment, 2020-2027

    7.4.1 China

    7.4.1.1 Market Estimates & Forecast, 2020-2027

    7.4.1.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.4.1.3 Market Estimates & Forecast, by Form, 2020-2027

    7.4.1.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.4.2 India

    7.4.2.1 Market Estimates & Forecast, 2020-2027

    7.4.2.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.4.2.3 Market Estimates & Forecast, by Form, 2020-2027

    7.4.2.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.4.3 Japan

    7.4.3.1 Market Estimates & Forecast, 2020-2027

    7.4.3.2 Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.4.3.3 Market Estimates & Forecast, by Form, 2020-2027

    7.4.3.4 Market Estimates & Forecast, by Ailment, 2020-2027

    7.5 RoW

    7.5. A Market Estimates & Forecast, 2020-2027

    7.5. B Market Estimates & Forecast, by Nutritional ingredients, 2020-2027

    7.5. C Market Estimates & Forecast, by Form, 2020-2027

    7.5. D Market Estimates & Forecast, by Ailment, 2020-2027

    Chapter 8 Competitor Profile

    8.1 Danone (France)

    8.1.1 Business Overview

    8.1.2 Financial Data

    8.1.3 Product Landscape

    8.1.4 Key Developments

    8.1.5 Business Strategy

    8.1.6 SWOT Analysis

    8.2 Nestlé (Switzerland)

    8.2.1 Business Overview

    8.2.2 Financial Data

    8.2.3 Product Landscape

    8.2.4 Key Developments

    8.2.5 Business Strategy

    8.2.6 SWOT Analysis

    8.3 Abbott (U.S.)

    8.3.1 Business Overview

    8.3.2 Financial Data

    8.3.3 Product Landscape

    8.3.4 Key Developments

    8.3.5 Business Strategy

    8.3.6 SWOT Analysis

    8.4 Mead Johnson & Company, LLC (U.S.)

    8.4.1 Business Overview

    8.4.2 Financial Data

    8.4.3 Product Landscape

    8.4.4 Key Developments

    8.4.5 Business Strategy

    8.4.6 SWOT Analysis

    8.5 Primus Pharmaceuticals Inc. (U.S.)

    8.5.1 Business Overview

    8.5.2 Financial Data

    8.5.3 Product Landscape

    8.5.4 Key Developments

    8.5.5 Business Strategy

    8.5.6 SWOT Analysis

    8.6 Targeted Medical Pharma Inc. (U.S.)

    8.6.1 Business Overview

    8.6.2 Financial Data

    8.6.3 Product Landscape

    8.6.4 Key Developments

    8.6.5 Business Strategy

    8.6.6 SWOT Analysis

    8.7 Fresenius Kabi AG (Germany)

    8.7.1 Business Overview

    8.7.2 Financial Data

    8.7.3 Product Landscape

    8.7.4 Key Developments

    8.7.5 Business Strategy

    8.7.6 SWOT Analysis

    Data Tables

    TABLE 1 PESTLE ANALYSIS – U.S.

    TABLE 2 PESTLE ANALYSIS- JAPAN

    TABLE 3 PESTLE ANALYSIS- CHINA

    TABLE 4 PESTLE ANALYSIS- FRANCE

    TABLE 5 PESTLE ANALYSIS- GERMANY

    TABLE 6 KEY SUPPLIERS OF MEDICAL FOODS MARKET

    TABLE 7 GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, (2020-2027), USD MILLION

    TABLE 8 GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY FORM, (2020-2027), USD MILLION

    TABLE 9 GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY AILMENT, (2020-2027), USD MILLION

    TABLE 10 GLOBAL MEDICAL FOODS MARKET SALES AND GROWTH RATE (2020-2027) USD MILLION

    TABLE 11 GLOBAL MARKET FOR MEDICAL FOODS MARKET TOP 5 COUNTRIES

    TABLE 12 GLOBAL MARKET FOR MEDICAL FOODS MARKET TOP COMPANIES-USD MILLION

    TABLE 13 NORTH AMERICAN GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, (2020-2027) USD MILLION

    TABLE 14 NORTH AMERICAN MARKET FOR MEDICAL FOODS MARKET, BY FORM, (2020-2027), USD MILLION

    TABLE 15 NORTH AMERICAN MARKET FOR MEDICAL FOODS MARKET, BY AILMENT, (2020-2027), USD MILLION

    TABLE 16 EUROPEAN GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, (2020-2027) USD MILLION

    TABLE 17 EUROPEAN MARKET FOR MEDICAL FOODS MARKET, BY FORM, (2020-2027), USD MILLION

    TABLE 18 EUROPEAN MARKET FOR MEDICAL FOODS MARKET, BY AILMENT, (2020-2027), USD MILLION

    TABLE 19 APAC GLOBAL MARKET FOR MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, (2020-2027) USD MILLION

    TABLE 20 APAC MARKET FOR MEDICAL FOODS MARKET, BY FORM, (2020-2027), USD MILLION

    TABLE 21 APAC MARKET FOR MEDICAL FOODS MARKET, BY AILMENT, (2020-2027), USD MILLION

    TABLE 22 REST OF THE WORLD MARKET FOR MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, (2020-2027) USD MILLION

    TABLE 23 REST OF THE WORLD MARKET FOR MEDICAL FOODS MARKET, BY FORM, (2020-2027), USD MILLION

    TABLE 24 REST OF THE WORLD MARKET FOR MEDICAL FOODS MARKET, BY AILMENT, (2020-2027), USD MILLION

    TABLE 25 COMPETITIVE LANDSCAPING BASED ON FINACIALS DURING THE YEAR 2020 

    Charts & Figures

    LIST OF FIGURES

    FIGURE 1 RESEARCH METHODOLOGY

    FIGURE 2 PRIMARY DATA ANALYSIS APPROACH

    FIGURE 3 SECONDARY DATA ANALYSIS APPROACH

    FIGURE 4 TRENDS IN MEDICAL FOODS MARKET IMPORTS 2020-2027

    FIGURE 5 GROWTH RATE IN MEDICAL FOODS MARKET IMPORTS 2020-2027

    FIGURE 6 MEDICAL FOODS MARKET IMPORTS MARKET SHARE BY TOP 5 IMPORTERS (2020 - 2027)

    FIGURE 7 TRENDS IN MEDICAL FOODS MARKET EXPORTS 2020-2027

    FIGURE 8 GROWTH RATE MEDICAL FOODS MARKET EXPORTS 2020-2027

    FIGURE 9 MEDICAL FOODS MARKET EXPORTS MARKET SHARE BY TOP 5 EXPORTERS (2020 - 2027)

    FIGURE 10 VALUE CHAIN ANALYSIS

    FIGURE 11 COST ANALYSIS: MEDICAL FOODS MARKET

    FIGURE 12 PORTER’S FIVE FORCES ANALYSIS

    FIGURE 13 GLOBAL MARKET FOR MEDICAL FOODS MARKET TRENDS BY NUTRITIONAL INGREDIENTS

    FIGURE 14 GLOBAL MARKET FOR MEDICAL FOODS MARKET TRENDS BY FORM

    FIGURE 15 GLOBAL MARKET FOR MEDICAL FOODS MARKET TRENDS BY AILMENT

    FIGURE 16 FINANCIALS